Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Electronic Caregiver Responds to Rural Health Crisis and CMS Leadership Shift: Addison Care Is the Next Step Beyond Telehealth
Healthcare & PharmaceuticalCompany Update

Electronic Caregiver Responds to Rural Health Crisis and CMS Leadership Shift: Addison Care Is the Next Step Beyond Telehealth

April 29, 2025 12:00 PM

As newly appointed CMS Administrator Dr. Mehmet Oz renews focus on telehealth to stabilize rural healthcare access, Electronic Caregiver, developer of the groundbreaking Addison Care platform, is urging a national shift from episodic telehealth to continuous, AI-powered TeleCare-a model designed for day-to-day support, chronic care, and preventive interventions both at home and at the bedside.While national headlines emphasize acute care...

Read more
Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application
Healthcare & PharmaceuticalCompany Update

Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application

April 29, 2025 11:30 AM

MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of cancer and other diseases, is pleased to announce the early completion of its preclinical trial for glioblastoma, a highly aggressive brain cancer. This milestone strengthens the company's FDA Orphan Drug Application and positions Exousia Pro to become a leader in innovative cancer treatments.Nearly...

Read more
The Hidden Cause of Back Pain No One Talks About - and the Surgeon Who's Changing Everything
Healthcare & PharmaceuticalCompany Update

The Hidden Cause of Back Pain No One Talks About - and the Surgeon Who's Changing Everything

April 29, 2025 11:00 AM

In the world of spine surgery, few conditions remain as misunderstood and underdiagnosed as Bertolotti Syndrome - a complex, often-overlooked cause of chronic lower back pain. Dr. Hooman Melamed, a world-renowned Orthopedic Spine Surgeon based in Beverly Hills, is pioneering a groundbreaking, motion-sparing solution for this debilitating condition - one that no other surgeon in the world performs.What is Bertolotti Syndrome?Bertolotti Syndrome...

Read more
Sound Physicians Launches Sound Practice Solutions - a Groundbreaking Approach to Hospital Performance & Revenue Optimization
Healthcare & PharmaceuticalProduct Announcements

Sound Physicians Launches Sound Practice Solutions - a Groundbreaking Approach to Hospital Performance & Revenue Optimization

April 29, 2025 10:00 AM

Sound Physicians today announced the launch of Sound Practice Solutions, a comprehensive suite of services and tools designed to help hospitals and health systems overcome persistent challenges in standardizing clinical protocols, operational efficiency, and revenue cycle management. Drawing on over two decades of multi-specialty expertise, Sound Practice Solutions provides a proven, at-risk partnership that empowers hospitals to achieve...

Read more
Alter Behavioral Health Launches Luxury Residential Crisis Center in San Juan Capistrano
Healthcare & PharmaceuticalCompany Update

Alter Behavioral Health Launches Luxury Residential Crisis Center in San Juan Capistrano

April 29, 2025 9:00 AM

Alter Behavioral Health announces the grand opening of its new Luxury Residential Crisis Center in San Juan Capistrano. This premier facility offers immediate crisis stabilization in a safe, welcoming setting focused on comfort and healing. It is now open and accepting clients needing urgent mental health intervention.Nestled in a tranquil residential area with breathtaking mountain views, this center provides a compassionate alternative to...

Read more
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025
Healthcare & PharmaceuticalEarnings

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025

April 29, 2025 9:00 AM

In the first calendar quarter (1Q) of 2025, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results consistent with its previously announced projections for calendar year 2025.Summary of results.The following is a summary comparison of 1Q 2025 with 1Q 2024 income statement measures:Revenues (Sales): (14.4%)Gross Profit (GP): (18.1%)Operating Income (OI): (18.8%)Net Income (NI): (23.1%)Earnings Per Share (EPS): (16.0%)Profit...

Read more
Netsmart Ranked #1 in Physical Therapy and Outpatient Rehabilitation EMR & Practice Management: Black Book Survey Highlights Critical Tech Trends in 2025
Healthcare & PharmaceuticalAwards

Netsmart Ranked #1 in Physical Therapy and Outpatient Rehabilitation EMR & Practice Management: Black Book Survey Highlights Critical Tech Trends in 2025

April 29, 2025 9:00 AM

Netsmart has been recognized as the top-rated provider of Electronic Medical Records(EMR) and PracticeManagement (PM) solutions for Physical Therapy (PT), Outpatient Rehabilitation and Speech Therapy practices in the 2025 Black Book Research Survey. In an independent evaluation of healthcare IT vendors, 902 rehabilitation and physical therapy physician practices assessed 58 EMR and PM solutions, with Netsmart TheraOffice® achieving the highest...

Read more
Vastian Automates Leapfrog Hospital Survey Binder into Quality Management System
Healthcare & PharmaceuticalCompany Update

Vastian Automates Leapfrog Hospital Survey Binder into Quality Management System

April 29, 2025 9:00 AM

Vastian, a leading provider of quality management software for hospitals and laboratories, is the first to electronically automate the Leapfrog Hospital Survey Binder into its quality management system application, Vastian Readiness. The Leapfrog Group, an independent national nonprofit focused on patient safety, executes its annual Leapfrog Hospital Survey assessing hospital safety, quality, and efficiency based on national performance measures...

Read more
Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology
Healthcare & PharmaceuticalCompany Update

Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology

April 29, 2025 9:00 AM

Ludwig Enterprises, Inc. (the "Company") today announced the acceptance for publication in the Journal of Clinical Oncology two abstracts related to its mRNA cancer program. These abstracts are titled: "Non-invasively Collected Buccal Cell mRNA Reveals Novel Breast Cancer Signal," and "A Novel Machine Learning Approach to Breast Cancer Screening Using Non-invasive mRNA Collection."Marvin S. Hausman MD, CSO of the Company, stated: "The ASCO 2025...

Read more
Gilead Sciences: AIDSVu Online Mapping Tool Helps Visualize HIV’s Impact in the United States
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Gilead Sciences: AIDSVu Online Mapping Tool Helps Visualize HIV’s Impact in the United States

April 29, 2025 8:35 AM

Gilead is committed to using its virology expertise to advance HIV treatment and prevention to help end the epidemic. Since 2010, the company has partnered with Emory University in Atlanta to launch AIDSVu - an online mapping tool that visualizes granular data related to the HIV epidemic in the United States.The tool was designed to help increase awareness and understanding of the impact of HIV across the U.S., especially in the South.AIDSVu...

Read more
Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Healthcare & PharmaceuticalCompany Update

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

April 29, 2025 8:30 AM

HUMACAO, PR and NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced that it has received Institutional Review Board (IRB) approval of the clinical trial protocol for its upcoming Phase I single-center clinical trial in the United States designed to evaluate safety, pharmacokinetics and...

Read more
RETRANSMISSION: Full Alliance Group, Inc. (OTC: FAGI) Establishes Aquaox Pure Solutions, LLC to Revolutionize Hypochlorous Acid Production with Nanobubble Technology
Healthcare & PharmaceuticalMergers and Acquisitions

RETRANSMISSION: Full Alliance Group, Inc. (OTC: FAGI) Establishes Aquaox Pure Solutions, LLC to Revolutionize Hypochlorous Acid Production with Nanobubble Technology

April 29, 2025 8:15 AM

Full Alliance Group, Inc. (OTC:FAGI) today announced the formation of its wholly owned subsidiary, Aquaox Pure Solutions, LLC. The new entity will manufacture pure hypochlorous acid (HOCl) utilizing advanced nanobubble technology, positioning the company to set new standards in efficacy and safety across multiple industries including healthcare, agriculture, water treatment, and consumer products.Michel Van Schaik, a globally recognized expert...

Read more
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
Healthcare & PharmaceuticalProduct Announcements

Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System

April 29, 2025 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and its aesthetic business, Solta Medical, announced today that Health Canada has granted medical device license clearance for Thermage® FLX, the latest generation of the globally-recognized Thermage® system for non-invasive skin tightening and contouring."The clearance of Thermage FLX in Canada is a positive development for our company and important...

Read more
CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Columbian Company
Healthcare & PharmaceuticalCompany Update

CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Columbian Company

April 29, 2025 8:00 AM

CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the cannabidiol (CBD) wellness industry, is proud to announce a major new manufacturing partnership with Thallos, a premier South American company headquartered in Colombia. Under this agreement, CBDL will take full control of the production, packaging, and labeling of a specialized line of high-potency CBD products exclusively for Thallos - a strategic move expected to significantly...

Read more
Retatrutide (LY3437943): A Novel Tri-agonist Peptide for Metabolic Disease Treatment
Healthcare & PharmaceuticalCompany Update

Retatrutide (LY3437943): A Novel Tri-agonist Peptide for Metabolic Disease Treatment

April 29, 2025 7:30 AM

Retatrutide, also known as LY3437943, is an innovative triple receptor agonist targeting glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Developed by Eli Lilly, it exhibits substantial promise for treating obesity, type 2 diabetes, and associated metabolic disorders. This article reviews recent scientific findings, mechanisms of action, clinical outcomes, and practical considerations...

Read more
Invitation to the Presentation of Cantargia's Interim Report for Q1 2025
Healthcare & PharmaceuticalCompany Update

Invitation to the Presentation of Cantargia's Interim Report for Q1 2025

April 29, 2025 7:15 AM

Cantargia (STO:CANTA) - Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) will publish the company's interim report for the first quarter of 2025 on Tuesday, May 13, 2025, at 07:00 a.m. CEST.In conjunction to the report, Cantargia invites investors, analysts, and media to an audiocast with teleconference (in English) on May 13, at 3:00 p.m. CEST, where Cantargia's interim CEO, Damian Marron, and CFO, Patrik Renblad, will present Cantargia...

Read more
Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It
Healthcare & PharmaceuticalCompany Update

Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It

April 29, 2025 6:30 AM

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, provides further details on its Measles drug development program herewith.Measles is likely to become endemic in the USA, according to modeling conducted by Stanford scientists...

Read more
Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India
Healthcare & PharmaceuticalProduct Announcements

Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India

April 29, 2025 6:00 AM

Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company revolutionizing orthopedic surgery, today announced it has obtained regulatory approval from India's Central Drugs Standard Control Organization ("CDSCO") to import its mBôs TKA system to conduct a 102-patient, multi-center clinical investigation evaluating the safety and effectiveness of the Monogram TKA System. The study will be conducted in...

Read more
Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025
Healthcare & PharmaceuticalEarnings

Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025

April 29, 2025 4:30 AM

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its interim statement for the first quarter of 2025 on Tuesday, 6 May 2025.The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The conference call will be held in English.Webcast detailsDate: Tuesday, 6 May 2025Time: 2.00 pm CEST (1.00 pm BST, 8.00 am EDT)To join the audio...

Read more
The Healthcare Impact Alliance Expands Connected Healthcare Ecosystem With Mendock Technology Smart Lock Integration
Healthcare & PharmaceuticalPartnerships

The Healthcare Impact Alliance Expands Connected Healthcare Ecosystem With Mendock Technology Smart Lock Integration

April 29, 2025 4:00 AM

The Healthcare Impact Alliance (The HIA) today announced a strategic partnership with Mendock Technology Co., Ltd., a leading manufacturer of smart security solutions, to integrate their advanced smart locks into the Lifeline connected healthcare ecosystem. This integration represents a significant advancement in emergency response capabilities for healthcare providers and first responders.The partnership will leverage The HIA Technology's WiFi...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?